Knowledge-Based Identification of Soluble Biomarkers: Hepatic Fibrosis in NAFLD as an Example

• Sandra Page,

  Affiliations Center for the Study of Chronic Metabolic Diseases, School of Systems Biology, College of Science, George Mason University, Fairfax, Virginia, United States of America, Betty and Guy Beatty Liver and Obesity Program, Inova Health System, Falls Church, Virginia, United States of America, Liver Diseases Branch of National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Aybike Birerdinc,

  Affiliations Center for the Study of Chronic Metabolic Diseases, School of Systems Biology, College of Science, George Mason University, Fairfax, Virginia, United States of America, Betty and Guy Beatty Liver and Obesity Program, Inova Health System, Falls Church, Virginia, United States of America

  ⨯
• Michael Estep,

  Affiliations Betty and Guy Beatty Liver and Obesity Program, Inova Health System, Falls Church, Virginia, United States of America, Center for Liver Diseases and Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia, United States of America

  ⨯
• Maria Stepanova,

  Affiliations Center for the Study of Chronic Metabolic Diseases, School of Systems Biology, College of Science, George Mason University, Fairfax, Virginia, United States of America, Betty and Guy Beatty Liver and Obesity Program, Inova Health System, Falls Church, Virginia, United States of America

  ⨯
• Arian Afendy,

  Affiliations Betty and Guy Beatty Liver and Obesity Program, Inova Health System, Falls Church, Virginia, United States of America, Center for Liver Diseases and Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia, United States of America

  ⨯
• Emanuel Petricoin,

  Affiliations Center for the Study of Chronic Metabolic Diseases, School of Systems Biology, College of Science, George Mason University, Fairfax, Virginia, United States of America, Center for Applied Proteomics and Molecular Medicine, School of Systems Biology, College of Science, George Mason University, Fairfax, Virginia, United States of America

  ⨯
• Zobair Younossi,

  Affiliations Betty and Guy Beatty Liver and Obesity Program, Inova Health System, Falls Church, Virginia, United States of America, Center for Liver Diseases and Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia, United States of America

  ⨯
• Vikas Chandhoke,

  Affiliation Center for the Study of Chronic Metabolic Diseases, School of Systems Biology, College of Science, George Mason University, Fairfax, Virginia, United States of America

  ⨯
• Ancha Baranova

  * E-mail: abaranov@gmu.edu

  Affiliations Center for the Study of Chronic Metabolic Diseases, School of Systems Biology, College of Science, George Mason University, Fairfax, Virginia, United States of America, Betty and Guy Beatty Liver and Obesity Program, Inova Health System, Falls Church, Virginia, United States of America, The Research Centre of Medical Genetics RAMS, Moscow, Russia

  ⨯